MNPR
Monopar Therapeutics Inc

3,318
Mkt Cap
$368.95M
Volume
266,094.00
52W High
$105.00
52W Low
$26.06
PE Ratio
-16.06
MNPR Fundamentals
Price
$55.21
Prev Close
$58.67
Open
$58.22
50D MA
$60.91
Beta
1.45
Avg. Volume
244,660.84
EPS (Annual)
-$4.11
P/B
2.60
Rev/Employee
$0.00
$23.17
Loading...
Loading...
News
all
press releases
Monopar Therapeutics Inc. $MNPR Shares Acquired by Ally Bridge Group NY LLC
Ally Bridge Group NY LLC increased its position in shares of Monopar Therapeutics Inc. (NASDAQ:MNPR - Free Report) by 86.6% in the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Recommendation of "Buy" from Brokerages
Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) have received an average rating of "Buy" from the thirteen ratings firms that are presently covering the firm, Marketbeat reports...
MarketBeat·23d ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) Earns Buy Rating from BTIG Research
BTIG Research reaffirmed a "buy" rating and set a $104.00 target price on shares of Monopar Therapeutics in a research report on Monday...
MarketBeat·27d ago
News Placeholder
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Up 28.3% in December
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 1,056,017 shares, a...
MarketBeat·2mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) CFO Quan Anh Vu Acquires 1,500 Shares
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) CFO Quan Anh Vu bought 1,500 shares of Monopar Therapeutics stock in a transaction dated Friday, December 26th. The stock was acquired at an...
MarketBeat·3mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) CFO Purchases 1,500 Shares
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) CFO Quan Anh Vu purchased 1,500 shares of the business's stock in a transaction dated Friday, December 26th. The shares were purchased at an...
MarketBeat·3mo ago
News Placeholder
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Update
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest...
MarketBeat·3mo ago
News Placeholder
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025
IONS, GPCR, MNPR and KOD more than double in 2025 as policy clarity, M&A revival and clinical wins lift biotech momentum into 2026.
Zacks·3mo ago
News Placeholder
Monopar Therapeutics Inc. (NASDAQ:MNPR) Given Average Recommendation of "Buy" by Brokerages
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen brokerages that are covering the firm, Marketbeat reports. One analyst has...
MarketBeat·3mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Monopar Therapeutics from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·3mo ago
<
1
2
...
>

Latest MNPR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.